Each panel provides an example of a phenotype from a phenotypic category. The bar graph shows the raw phenotypic values (i.e., before necessary transformation and covariate adjustments) for each animal available. The order of animals on the x-axis are determined by ranking phenotypic values from the lowest to highest. Abbreviations: BL, baseline; SDR, sleep deprivation recovery; Rst, after restraint stress.
SUPPLEMENTAL TABLES
Due to the amount of contents, all five supplemental tables are provided as Excel files. We provide information of network module memberships and associated statistics, gene lists used for enrichment analysis, module GO annotations, module-trait associations, as well as the list of all identified key driver genes for the Turquoise and Mediumpurple2 modules.
EXTENDED EXPERIMENTAL PROCEDURES

Stress Procedures and Data collection
Novel Exposed Environments
At 6 and 10 weeks of age, mice were placed in three separate brightly-lit, exposed novel environments for five minutes each. These included the elevated plus maze and the open field (done on subsequent days, 6 weeks of age) and the elevated zero maze (10 weeks of age). Data were collected and analyzed using LimeLight software (Actimetrics, Wilmette, IL), as previously described (Fitzpatrick et al., 2012) . Each of the novel environments was thoroughly cleaned with 70% ethanol and allowed to dry between mice.
Blood Pressure
At 6, 9, and 12 weeks of age, diastolic and systolic blood pressure were measured via volume pressure recording in the tail vein using the CODA High Throughput device (Kent Scientific, Torrington, CT) according to the manufacturer's instructions. Mice were allowed to acclimate to the restraint cylinder and tailcuff device for approximately 15 minutes on a warmed platform prior to the measurements. Using the manufacturer-recommended protocol, multiple measurements were taken over a period of several minutes and the included software package calculated an average value for each animal.
Restraint
At 7 weeks of age, mice were subjected to restraint stress consisting of 15 minutes spent physically restrained in a plastic tube restrainer. All restraint tubes were thoroughly washed and dried between uses. Blood samples were collected from a nick in the tail tip at baseline (0 minutes, prior to restraint), immediately following restraint (15 minutes), and 30 and 60 minutes after the baseline measurement and assayed for serum corticosterone and glucose levels. Corticosterone levels were measured using the Corticosterone Enzyme Immunoassay Kit (Assay Designs, Ann Arbor, MI), and glucose levels were measured using the LabAssay Glucose assay (Wako Chemicals, Richmond, VA), following the protocols provided by manufacturers.
Forced Swimming
At 8 weeks of age, animals were exposed to two consecutive days of forced swimming. Mice were placed one at a time in a beaker (25 cm tall, 15 cm diameter) of water (23.5°±0.5°C) filled to a depth of 16 cm for six minutes, after which the animal was removed and allowed to dry in a clean cage placed halfway over a heating pad, allowing free regulation of temperature preference. Fecal boli were removed between test mice and the beakers were cleaned and dried thoroughly between the two runs. All mice were tested in the same order on the consecutive testing days. The videos were scored for overall activity levels in each testing period using a custom-designed Matlab program, as previously described (Gao et al., 2014) . In addition to quantifying movements during the 6 minute forced swim, the minute-by-minute activity data were fitted with a power law function, = − (where A is the activity at time t), to model the decay of the activity intensity as a function of time. We use the decay power  as a measure of behavioral despair, as higher  indicates a faster rate at which the animal reduces swimming activity.
Fear Conditioning
At 9 weeks of age, mice were subjected to three sequential days of an eight minute long fear conditioning protocol, followed by the same test 21 days later (at 12 weeks of age, termed "retention"). Animals were placed in a closed and lighted fear conditioning chamber containing a scent cue consisting of filter paper treated with five mL of lemon oil. The first three minutes of the test, termed the "baseline" period, contained no auditory cues or shocks. At the conclusion of this first three minute period, mice were presented with a 30 second auditory tone cue, the last two seconds of which contained a simultaneous 0.6 mA foot shock, followed by 60 seconds of no stimulus. The 30 second cue-shock combination was repeated three more times (for a total of four cue-shock presentations) with 60 seconds between presentations. After the conclusion of the last cue-shock presentation, mice were placed back into their home cages. Freezing behavior was quantified with the use of a custom software package (FreezeFrame, Actimetrics, Wilmette, IL). The testing chambers were wiped with ethanol and allowed to dry between mice and the removable floor grids of the chambers were also washed and dried between test animals.
Social Defeat
At 10 weeks of age, mice were subjected to three consecutive days of social defeat. This consisted of the test mouse being placed in the larger, established home cage of an older (>6 months) CD1 male breeder mouse. Female mice were removed from the CD1 male's cage for the procedure, and cages were not changed less than 3 days prior to the procedure. The test mouse was placed in the center of the cage, and once attacked by the resident male, the test mouse was confined inside an inverted stainless steel test tube washing basket within the home cage of the breeder mouse for one hour, to allow visual, olfactory, and auditory exposure to the resident without risking injury to the test animal. Animals were observed throughout to insure that the test animal was not physically harmed by the resident male. Circulating blood was collected via the tail immediately following the one hour exposure time period on the 3 rd day of this 3-day procedure. Blood levels of corticosterone and glucose were measured using the same method describe above.
Cold Exposure
At 11 weeks of age, mice were subjected to three consecutive days of 1-hr exposure to cold environments. This stressor consisted of having the home cage relocated to a 5°±1°C chamber for one hour on each of the three days. Body temperature was measured, using a rectal probe, at the end of the one-hour cold exposure period on each of the three days.
Glucose Tolerance Test
At 12 weeks of age, mice were subjected to a glucose tolerance test as a metabolic stressor. The animals were fasted for six hours starting at the onset of the light period, and then given an intraperitoneal (IP) bolus injection of 2 g/kg of a 45% glucose solution. Circulating blood was collected via the tail at baseline (0 minutes, prior to glucose administration), and subsequently at 30, 60 and 120 minutes following the baseline measurement. Blood levels of corticosterone and glucose were measured using the same method describe above.
Sleep Procedures
Sleep Implant Surgery
Surgical procedures were performed in a ventilated, specially-equipped surgical suite, and standard aseptic techniques were used. At 13-14 weeks of age, mice were surgically implanted with a headmount (Pinnacle Technology, Lawrence, KS) for sleep recording under a cocktail of Ketamine HCL 98 mg/kg and Xylazine 10 mg/kg anesthesia given by IP injection. The headmount consists of three electroencephalographic (EEG) electrodes and two electromyographic (EMG) electrodes affixed to a printed circuit board, which is attached to the exposed skull via a small amount of cyanoacrylate (3M, United States) and four stainless steel screws (0.10" screws for anterior positions; 0.12" screws for posterior positions, Pinnacle Technology, Lawrence, KS) which serve as the EEG leads. Using a mouse stereotaxic apparatus (David Kopf Instruments), the implant is positioned on the skull such that the front edge of the implant is placed 3.0-3.5 mm anterior to bregma. This configuration ensures that all four screws are placed in the cerebral cortex region of an adult mouse. A small pocket is then made in the nuchal muscles using a pair of forceps for the placement of the EMG wires. Dental acrylic (Lang Dental Manufacturing Co., Wheeling, IL) is used to seal and protect the headmount, and the skin is closed around the headmount with a single suture using 5-0 chromic gut (United States Surgical, Norwalk, CT) at the front and back of the implant. The analgesic meloxicam (2 mg/kg) was administered via subcutaneous injection at the end of surgery while the animal was still anesthetized and once daily for the following two days.
Sleep Recording Setup
Seven days after the implant procedure, mice were placed into the sleep recording chambers (25 cm in diameter and 20 cm tall, Pinnacle Technology, Lawrence, KS) and allowed to acclimate to the chamber for three days prior to connecting the headmount to the transmission tether, and then given an additional two days to acclimate to the tether connection prior to any data collection. EEG and EMG signals were recorded from the mice at a sampling rate of 1000 Hz, using hardware and software from Pinnacle Technology (Lawrence, KS). The headmount was attached to a preamplifier that provided an initial 100-fold amplification and high-pass filtering (0.5 Hz for EEG and 10 Hz for EMG) of the signal. The signal was then routed through a tether to the acquisition system, which provided additional signal amplification and filtering before transmitting the EEG and EMG signals to a computer for storage prior to subsequent analyses (see Analysis Procedures).
EEG and EMG were collected from each mouse continuously for a period of approximately six days. The first portion of this recording period consisted of a 24-hour baseline period starting from ZT0 (onset of light period). Next, a six-hour sleep deprivation period (ZT0-6) was recorded, followed by a 24-hour sleep recovery period starting from the offset of sleep deprivation at ZT6. The subsequent portion of the recording included an 18-hour interval that was not analyzed, followed by a second 24-hour baseline period, which again began at ZT0. Six hours after the end of this baseline period, mice were then subjected to restraint stress for 15 minutes at ZT6, followed by a 24-hour response period.
Sleep Deprivation Procedure
Sleep deprivation was achieved using a commercially available sleep deprivation system integrated into the sleep recording chambers (Pinnacle Technology, Lawrence, KS), which simulates the gentle handling technique via a rotating metal bar (22 cm in length) attached to a post at the center of the cage. For the six-hour sleep deprivation period, the bar's rotation speed was set at seven rotations per minute with reversals of rotation direction (i.e., clockwise vs. counterclockwise) set to occur at semi-random intervals of 10 ± 10 seconds. The bar remained stationary during all other recording periods.
Restraint Procedure
Mice were subjected to a restraint stress procedure at ZT6 for 15 minutes, during which they were placed inside a 118 ml translucent polypropylene cup with a lid (Covidien, Mansfield, MA), which was modified with several holes for airflow and a 1 x 3.5 cm cut-out in the lid to accommodate the sleep recording tether. The restraint apparatus remained in their home cage during the restraint procedure. Upon completion of the restraint period, mice were removed from the restraint apparatus and their responding sleep behavior was recorded for the following 24 hours.
Sleep Scoring Methods
Each sleep EEG/EMG recording was divided into 10-second epochs for scoring, and each epoch was scored as wake, NREM sleep, or REM sleep. To aid in sleep scoring, we used a naïve Bayes classifier algorithm (Rytkonen et al., 2011) implemented in Matlab. First, approximately four hours of the recording were manually scored and used as training for the classifier. Input features for the classifier were EMG power and EEG power spectral density divided into 20 power band distinctions. A rejection level was set based on posterior probabilities, with a cutoff of 0.95 for NREM and wake and 0.999 for REM epochs, such that should the algorithm be unable to classify an epoch it was left unscored. The remaining unscored epochs were then manually scored to completion. The naïve Bayes classifier scored approximately 90% of the epochs in the recording period with these rejection criteria, leaving the remaining 10% of the recording to be completed manually.
Sleep-wake parameters were calculated for each 12 hour light period, 12 hour dark period, each 24 hour period, the six-hour sleep deprivation period, as well as each one-hour and six-hour subdivision of each of those periods using a quantification system designed in-house and ran on the Microsoft Excel platform. State amounts were determined by summing all epochs of that state in the given period. Sleep architecture was assessed by determining the number of arousals from sleep (a 10-second epoch of wakefulness bounded by NREM or REM sleep), stage shifts (number of transitions between ten second epochs of wake, NREM, and REM), sleep/wake bouts (at least two consecutive epochs of wake, NREM, REM or total sleep ending with the initiation of a bout in a different state) and the average duration (minutes) of sleep/wake bouts.
The median inter-REM interval was defined as the median time between the end of one REM sleep episode and the beginning of the next REM sleep episode. Latencies to NREM sleep and REM sleep after sleep deprivation were determined by the number of minutes from the end of sleep deprivation until the animal enters the respective sleep state.
For quantitative analysis of the EEG signal, each 10-second scoring epoch was divided into five two-second intervals and subjected to Fast Fourier Transformation, which included a range of 1-30 Hz. For all epochs of wake, NREM and REM sleep, the EEG power in the delta (1-4 Hz), theta I (4-8 Hz), theta II (8-11 Hz), sigma (11-15 Hz) and beta (15-30 Hz) frequency ranges were calculated. This process yielded values of relative power in each of the frequency bands. Average time of NREM and REM were calculated using circular statistics, such that the vector angle is the average time on the 24-hour clock while the vector length was used as a measure of variance, ranging from zero to one, representing even distribution to complete consolidation, respectively.
Terminal Measurements
Multiple measurements and tissues were collected at the time of necropsy. Mice were euthanized at ZT6 by conscious decapitation, and brain regions were immediately dissected and frozen within five minutes. Brain structures were dissected on a dry ice-cooled, sterile tissueculture plate with the assistance of a dissecting microscope to identify structural landmarks. Dissecting instruments were cleaned in DEPC-treated water, ethanol and then chloroform between mice to reduce the potential for RNAase exposure and cross-contamination of samples. Samples were weighed, then frozen in liquid nitrogen and stored at -80° C until RNA isolation.
Trunk blood was collected and serum was isolated for various measurements, all of which were performed using commercial ELISA kits according to the manufacturer's instructions and protocol. Thyroid hormone levels were measured using the MILLIPLEX® MAP Rat Thyroid Hormone Panel Kit (EMD Millipore, Darmstadt, Germany). Cytokines were measured using the MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel Kit (EMD Millipore, Darmstadt, Germany). The various white blood cell types were measured using fresh blood samples ran in a BD LSR II Flow Cytometer (BD Biosciences, San Jose, CA) and a combination of four markers: PE-Cy 7 Mouse Anti-Mouse CD45.4, FITC Hamster Anti-Mouse CD3e, Alexa Fluor 647 Rat Anti-Mouse CD19 (BD Biosciences, San Jose, CA), and Anti-Mouse CD11b eFluor 450 (eBioscience, San Diego, CA).
Telomerase activity was measured in the liver and the testis (right side) using the telomeric repeat amplification protocol [TRAP; (Kim et al., 1994; Kim and Wu, 1997) ], performed with a Quantitative Telomerase Detection (QTD) Kit (Allied Biotech, Vallejo, CA). We prepared tissue extracts and performed the Telomerase Activity Assay using real-time PCR following the instructions of QTD Kit Manual. We used 1:5 serial dilutions of the QTD Kitprovided control template to establish a standard curve, and quantified the amount of telomeric repeats produced by telomerase in a tissue extract from a given sample.
Phenotypic Data Preparation
A total of 328 phenotypes from the chronic stress and sleep measurement procedures were included in the analysis. Phenotypic data were first examined for outliers and distribution. Outliers were excluded only if they fell outside the three inter-quartile-range while the rest of the samples were normally distributed. Then, for each trait, we used the Yeo-Johnson procedure (Yeo and Johnson, 2000) , an extended Box-Cox power transformation technique implemented in r/car package, to determine whether transformation is needed using a likelihood ratio test, and to transform the data to a distribution closest to normal when the likelihood test indicates transformation is needed. We then investigated the influence of potential experimental covariates, such as animal cohorts and housing. For each potential covariate, ANOVA p-values were calculated for all the phenotypes against the covariate. These p-values are expected to exhibit a uniform distribution if the potential covariate does not have widespread effects. The pvalues for a potential covariate were visualized in a q-q plot against theoretical quartiles from a uniform distribution to identify covariates that produce large proportion of small p-values. Animal cohort was found to have a widespread effect on phenotypic data, and thus all phenotypes were adjusted for animal cohort by fitting to a robust linear model, then taking the intercept + residuals as the adjusted values. We also investigated the effects of test-specific covariates, such as the effect of test station in phenotypes measured in the elevated plus maze test, and adjusted specific phenotypes accordingly when needed.
Phenotypes were functionally grouped into 29 categories. For baseline sleep phenotypes, factor analysis were performed using STATISTICA (v12.0A, StatSoft) to verify the functional categorization, similar to previous studies (Winrow et al., 2009 ). The results of the factor analysis are provided in Table S1 . Sleep phenotypes measured in recovery after sleep deprivation and sleep after restraint stress were categorized accordingly based on the categorization of baseline sleep phenotypes. In addition to these sleep categories confirmed by factor analysis, a total of 93 sleep measurements that were not grouped into any of these sleep categories were grouped as the 29 th phenotypic category, named "Other sleep phenotypes".
Genotyping DNA samples were isolated using phenol-chloroform from the tails of the chronically stressed (B6 x A/J) F2 mice. Genotyping was performed using the Illumina Mouse Medium Density Single Nucleotide Polymorphism (SNP) array at the Northwestern University Genomics Center. To ensure high-quality genotyping data for downstream analysis, we included DNA samples from four B6, two A/J and two (B6 x A/J) F1 animals during genotyping as an internal control to identify and remove non-informative and unreliable SNP markers. SNP markers with low call rates (< 95%) and those that do not fit with the expected pattern of Mendelian segregation (i.e., indication for strong segregation distortion or genotyping error; chi-square tests p < 0.001) were also removed. Possible genotype errors were further scrutinized by examining for abnormal frequent recombination at proximal locations. Any questionable genotypes were set to missing. Animals with high rates of frequent recombination were excluded from the analysis. Finally, three pairs of animals with an unexpected high rate of identical genotypes (>6 standard deviations from the mean) were also excluded from analysis. After these quality control steps, the final genotypic data consist of 297 animals genotyped at 731 SNP markers. These markers provided sufficient coverage of the entire genome, with a maximum space between adjacent SNPs of ~14 cM.
RNA-Seq and expression profiling RNA samples were extracted using TRIzol® reagent (Life Technologies, Grand Island, NY) from the striatum of a random subset of 100 F2 mice, and were then shipped to the Genomics Core Facility at the Icahn School of Medicine at Mount Sinai. Sample integrity was assessed using either an Agilent 2100 Bioanalyzer with the RNA 6000 Nano assay or an Agilent 2200 TapeStation with the R6K ScreenTape (Agilent, Santa Clara, CA). The average RIN values were above 9 for all processed total RNA samples. The standard TruSeq RNA Sample Prep Kit v2 protocol (Illumina, San Diego, CA) was used to prepare the sequencing library. Briefly, the cDNA was synthesized from poly-A-selected and then fragmented total RNA using random hexamers, followed by end-repair and ligation with appropriate sequencing adaptors. The libraries were then subject to size selection and was purified using AMPure XP beads (Beckman Coulter, Brea, CA). Barcode bases (6 bp) were introduced at one end of the adaptors during PCR amplification steps. The size and concentration of the cDNA libraries was measured by Bioanalyzer and Qubit fluorometry (Life Technologies, Grand Island, NY) before sequencing. The cDNA libraries were sequenced on the Illumina HiSeq 2500 System with 100 nucleotide single-end reads, according to the standard manufacturer's protocol (Illumina, San Diego, CA).
Raw 100 bp cDNA reads were aligned to the Ensembl NCBIM37 mouse reference genome via the popular wrapper tophat , which uses bowtie1 (Langmead et al., 2009 ) and a spliced junction mapper to treat the problem of spliced gap alignment. Nearly default settings were used with the exception of disabling coverage-based junction detection, which artificially constricts candidate splice junctions to GT-AG (thus losing e.g. GCAG and ATAC) and is only useful for relatively short (<= 75 bp.) reads. Raw read count values were deduced from quantitation against the NCBIM37 annotation features using the package htseq with a strict intersection criterion (reads must be completely enclosed within genic feature, i.e. zero overhang), and these raw values in turn were normalized for median coverage across all samples on a genewise basis. In this manner an N x M matrix, where N is the number of genes and M is the number of samples, was constructed and used for downstream analysis.
Based on the distribution of count values, the entire mode of low count values was deleted since it likely corresponds to mapping or other technical errors. The resulting data contain a total of 26,927 genes. This expression dataset was then investigated for influences from potential covariates, including testing cohorts and process variables of RNA preparation and sequencing. The identification of covariates with significant effects was the same as described for phenotypic measurements. Animal cohorts and RNA preparation batches were subsequently identified as significant covariates, and expression data of all genes were then adjusted for these selected covariates by fitting them in a robust linear model and taking the intercept + residuals as the adjusted expression values. Additionally, principal components were extracted from the covariate-adjusted expression data, as they can capture additional unknown factors that influenced gene expression. The first few principal components that were not driven by genetic factors (i.e., did not yield QTL) were selected to further adjust expression data by fitting with a robust linear model. For this expression dataset, the first three principal components were used. Finally, adjusted expression data were inverse normal-transformed and were then for downstream analyses.
Analysis Procedures
Mapping of Phenotypic QTL and Expression QTL
Phenotypic QTL and Expression QTL (eQTL) mapping was performed to identify genetic loci linked to variations in stress/sleep phenotypes and striatal gene expression using the r/qtl package (Broman et al., 2003) . We used Haley-Knott (HK) regression for the genome-wide QTL and eQTL scan. To estimate false discovery rates (FDR) for phenotypic QTL, we permuted the dataset 1000 times (i.e., scrambling the connection between the sample ID of genotype data and the sample ID of phenotypic data, while keeping intact the data structures and relationships within both the genotypic data and the phenotypic data). P-values from permuted datasets together with p-values from the real dataset were then used for estimation of FDR using the r/fdrci package (Millstein and Volfson, 2013) . For eQTL, we permuted the dataset 500 times and separately estimated FDR for cis-eQTL (defined as the locus and gene located on the same chromosome) and trans-eQTL.
Causality test to identify QTL candidate genes
We compared the peak positions of eQTL to those of the phenotypic QTL. When the peak-peak distance between a phenotypic QTL and an eQTL was less than 30 cM, they were considered overlapping, and the midpoint between peaks was then treated as the new joint QTL location. We then subjected the combination of the phenotype, genotype at joint QTL location (represented by the closest SNP genotype), and expression of the gene to a causality test to determine whether the gene expression mediates the effect of the QTL, causing the phenotypic variation (Millstein et al., 2011; Millstein et al., 2009; Schadt et al., 2005) . Briefly, for a combination of locus (L), gene expression (G) and trait (T), the causality of G to T is defined by a set of 4 conditions: 1) L and T are associated, 2) L is associated with G|T, 3) G is associated with T|L, and 4) L is independent of T|G. For conditions 1) through 3), standard F tests for linear models were used to compute p-values for each condition. For condition 4), the test statistic is compared to a bootstrap-based empirical null distribution ) and, in this study, 1000 bootstraps were used. The final result of the causal inference test, an omnibus pvalue, is defined as the largest p-value of all four component tests. Due to the conservative nature of the causal inference test, we included phenotypic QTL and eQTL at less stringent thresholds. 272 QTL influencing phenotypes in the 15 selected categories were included at LOD > 2.5, while 5080 cis-eQTL (LOD > 2.5) and 234 trans-eQTL (LOD > 5.5) were included at FDR < 0.2. These inclusion criteria gave a total of 57,918 phenotype-genotype-expression combinations for causal inference testing.
Module Construction and Trait Correlation
We generated coexpression modules with RNA-sequencing expression data, using weighted gene coexpression analysis (Zhang and Horvath, 2005) . Linear relationships between gene expression are described by their pairwise Pearson correlation. We define the adjacency matrix of the gene expression graph as the Pearson correlation raised to a positive power, β, which is then related to a "scale-free" power law connectivity distribution p(k) by regressing log(p(k)) on log(k) (Zhang and Horvath, 2005) . The adjacency matrix is further quadratically transformed to take into account nearest-neighbor links via topological overlap matrix (TOM), which has been shown to better depict biological interactions and thus segregate relevant modules (Ravasz et al., 2002) . A hierarchical clustering method then groups genes based upon their topological overlap, and these groups are segregated into modules by implementing the Dynamic Tree Cut algorithm (Langfelder et al., 2008) . Colors are used to identify coexpression modules, and the grey module identifies genes that do not segregate into any particular module. We used DAVID v6.7 (Huang et al., 2009) to assess the functional annotation (GO and KEGG) for each module, and we report Bonferroni corrected p-values and fold enrichment, as provided by DAVID. For enrichment analysis using external gene sets from Allen Brain Atlas and Mouse Genome Database, Fischer's exact test was performed. Fold enrichment is reported in all cases and Bonferroni corrected p-value is reported when appropriate. Specific gene sets are included in (Table S5) .
Gene modules can be dimensionally reduced into their first principal components (module eigengene). To determine module-trait relationships, these module eigengenes were correlated with phenotype measures by Spearman correlation, and their corresponding p-values were calculated. The false discovery rate was also estimated by randomly permuting the sample order of the phenotype data. A module-trait relationship was deemed significant when both its pvalue and FDR were < 0.05. Modules were then ranked for each phenotypic category based on the number of significant module-trait relationships within the category. Module ranking for multiple categories was determined by their composite rankings for each category, in order to control for category size.
Reconstructing Bayesian Networks from RNA-Seq Data
In this analysis, we reconstructed Bayesian networks (BN), which are directed acyclic graphs for which edges represent conditional probability distributions of each node given the state of its parent node (Pearl, 1988; Zhu et al., 2004) . In our networks, each node represents gene expression of a gene, and the conditional probability between nodes reflects the relationship between the expression of those genes. In our networks, the conditional probability distributions also capture stochasticity and noise in gene expression. By Bayes formula, we can determine the likelihood of a network model M, given our data, D, and our prior belief in the validity of our model, P(M). As such, Bayes formula states: P(M|D) = P(D|M) * P(M) / P(D).
We used a Monte Carlo Markov Chain (MCMC) simulation to reconstruct one thousand gene networks that are plausible given our data (Madigan et al., 1995) . In each simulation, random changes are introduced into a null network. Edges are flipped, deleted, or added, and they are only accepted when the random change improves the fit of the network to the data, as assessed by using Bayesian Information Criterion (BIC). BIC is conservative to overfitting since models with more parameters are essentially assigned lower prior probabilities, P(M).
We then generated a consensus network by only keeping edges that appear in more than 30% of the 1,000 reconstructions, an previously reported ideal threshold for balancing sensitivity and specificity (Zhu et al., 2007) . To reconstruct the directed acyclic graph from the consensus network, some edges need to be removed. An edge is removed only if it satisfies two conditions: (1) it is in a loop, (2) it is the edge in the loop that appears in the fewest number of reconstructions. In this paper, we reconstructed a single consensus Bayesian network from 18,460 genes with greatest variance across the mouse population, in order to reliably model the entire gene-gene interaction landscape, agnostic to any a priori (i.e. module) organization.
Using genetic information as priors in building the Bayesian Network
Although edges in Bayesian networks are directed, they do not generally contain causal information. Models for any two nodes, A and B, have equal probability distributions since p(A|B)*p(B) = p(B|A)*p(A). Graphically, this means that AB and BA are causally indistinguishable. For models with any three nodes, there are several arrangements that are mathematically identical. For example, "A B  C", "A  B  C", and "A  B  C" are Markov equivalent. All three structures model that A and C are conditionally independent (there is no direct edge between A and C) and A  B is independent of B  C. These three models are also mathematically equivalent. However, there are some structures that do not have a Markov equivalent, so we can infer causality: AB C.
To assist us in inferring causality in Markov equivalent structures, we include genetic data in the Bayesian network reconstruction algorithm (Zhu et al., 2004) . We use eQTL data as priors by allowing genes with cis-eQTLs to be parents of genes without cis-eQTLs and preventing genes without cis-eQTLs to be parents of genes with cis-eQTLs. Information of 3,982 cis-eQTL at FDR < 0.10 (LOD>2.96) were used. This method breaks the symmetry in Markov equivalent structures, allowing causal inferences to be made in structures that were previously causally indistinguishable. Integrating genetic data improves network reconstruction, as validated by simulation (Zhu et al., 2007) and in vivo experimentation (Zhu et al., 2004; Zhu et al., 2008) .
Identifying Key Drivers of Module Sub-networks
For identifying key causal regulators in our Bayesian network, we calculate enrichment statistics for each gene in a gene set of interest (Zhang and Zhu, 2013) . In this analysis, our modules are our gene sets of interest. We calculate the size of the h-layer neighborhood (HLN) downstream of each gene in our gene set. Nodes whose HLN is greater than mean(μ) + σ(μ) are candidate key drivers, where μ is the size of the respective HLN of each gene in our gene set. Candidate key drivers are considered "global" key drivers if they do not have a parent node, or if they have out-degrees above mean(d) + 2σ(d), where d is out-degrees for all the nodes. Otherwise, they are referred to as "local" key drivers. This method identifies nodes with significantly more downstream partners than the average node in the gene set.
To determine the functional relevance of identified key drivers in the Turquoise module, we queried the NHGRI GWAS Catalog (Welter et al., 2014) and collected a list of GWAS candidate genes associated with neuropsychiatric disorders (Table S5 ). Mouse homologs of the collected GWAS genes were identified using homology information provided by Ensembl. In case of many-to-many homology, all possible pairs of human and mouse genes were kept. For enrichment analysis, we used Fisher's exact test. We only considered mouse genes that have human homologs in order to avoid bias due to un-balanced matching of homology between mice and humans.
